Table 3 Correlations between plasma sclerostin levels and AD biomarkers among all participants and subgroups stratified by brain Aβ status.
All participants | Aβ− | Aβ+ | ||||
|---|---|---|---|---|---|---|
ρ | P | ρ | P | ρ | P | |
NFL | 0.337 | <0.001 | 0.445 | <0.001 | 0.095 | 0.587 |
GFAP | 0.314 | 0.001 | 0.218 | 0.081 | 0.067 | 0.703 |
t-tau | −0.017 | 0.865 | −0.018 | 0.889 | −0.267 | 0.121 |
p-tau181 | 0.393 | <0.001 | 0.279 | 0.025 | 0.143 | 0.434 |
p-tau231 | 0.316 | 0.002 | 0.241 | 0.053 | 0.114 | 0.541 |
Aβ42 | 0.097 | 0.348 | 0.217 | 0.090 | 0.061 | 0.737 |
Aβ40 | 0.283 | 0.005 | 0.336 | 0.007 | 0.153 | 0.395 |
Aβ42/40 | −0.155 | 0.133 | −0.076 | 0.559 | −0.128 | 0.479 |